Runzi Sun

609 total citations
17 papers, 452 citations indexed

About

Runzi Sun is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Runzi Sun has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Runzi Sun's work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (4 papers). Runzi Sun is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (4 papers). Runzi Sun collaborates with scholars based in United States, China and Taiwan. Runzi Sun's co-authors include Binfeng Lu, Jingting Jiang, Song Li, Zhuoya Wan, Lujun Chen, Yixian Huang, Ziqian Zhang, Zhangyi Luo, Haozhe Huang and Yuang Chen and has published in prestigious journals such as Nature Nanotechnology, Biomaterials and Science Advances.

In The Last Decade

Runzi Sun

17 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Runzi Sun United States	13	246	177	133	77	58	17	452
Xiao Su China	6	285 1.2×	202 1.1×	271 2.0×	85 1.1×	40 0.7×	9	543
Feyza Gül Özbay Kurt Germany	10	287 1.2×	192 1.1×	159 1.2×	69 0.9×	31 0.5×	14	543
Jared M. Newton United States	12	140 0.6×	184 1.0×	166 1.2×	97 1.3×	26 0.4×	19	424
Iliana Tenvooren United States	7	248 1.0×	257 1.5×	165 1.2×	66 0.9×	28 0.5×	13	536
Dipakkumar R. Prajapati United States	8	137 0.6×	167 0.9×	147 1.1×	65 0.8×	44 0.8×	15	344
María Jesús García-Granda Spain	5	301 1.2×	367 2.1×	144 1.1×	85 1.1×	35 0.6×	5	575
Renske J.E. van den Bijgaart Netherlands	11	145 0.6×	223 1.3×	149 1.1×	210 2.7×	31 0.5×	19	575
Ana Micaela Carnaz Simões Denmark	5	220 0.9×	263 1.5×	78 0.6×	79 1.0×	18 0.3×	8	432
Aaron T. Alpar United States	10	232 0.9×	190 1.1×	166 1.2×	83 1.1×	30 0.5×	18	454

Countries citing papers authored by Runzi Sun

Since Specialization

Citations

This map shows the geographic impact of Runzi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runzi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runzi Sun more than expected).

Fields of papers citing papers by Runzi Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runzi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runzi Sun. The network helps show where Runzi Sun may publish in the future.

Co-authorship network of co-authors of Runzi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Runzi Sun. A scholar is included among the top collaborators of Runzi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runzi Sun. Runzi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wu, Shaoxian, Hao Huang, Runzi Sun, et al.. (2023). Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Research Communications. 3(8). 1460–1472. 8 indexed citations

Sun, Runzi, Hongyu Zhao, Haochen Li, et al.. (2023). Amphiregulin couples IL1RL1 ⁺ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Science Advances. 9(34). eadd7399–eadd7399. 31 indexed citations

Chen, Yuang, Yixian Huang, Zhangyi Luo, et al.. (2022). Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy. Nature Nanotechnology. 18(2). 193–204. 87 indexed citations

Sun, Runzi, et al.. (2022). The IL-1 family in tumorigenesis and antitumor immunity. Seminars in Cancer Biology. 86(Pt 2). 280–295. 37 indexed citations

Chen, Lujun, Hao Huang, Xiao Zheng, et al.. (2022). IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts. Journal for ImmunoTherapy of Cancer. 10(9). e004585–e004585. 24 indexed citations

Xie, Yang, Runzi Sun, Li Gao, et al.. (2022). Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma. Hepatology Communications. 6(5). 1123–1139. 10 indexed citations

Chen, Yuang, Yixian Huang, Haozhe Huang, et al.. (2021). Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination. Molecular Therapy — Nucleic Acids. 26. 594–602. 11 indexed citations

Wan, Zhuoya, Runzi Sun, Yang‐Wuyue Liu, et al.. (2021). Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science Advances. 7(50). eabj4226–eabj4226. 23 indexed citations

Wu, Shaoxian, Runzi Sun, Bo Tan, et al.. (2021). The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy. Frontiers in Cell and Developmental Biology. 9. 779865–779865. 22 indexed citations

10.

Huang, Haozhe, Yixian Huang, Yuang Chen, et al.. (2021). A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death. Biomaterials. 270. 120708–120708. 19 indexed citations

11.

Sun, Runzi, Yixian Wu, Huijun Zhou, et al.. (2021). Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells. Frontiers in Cell and Developmental Biology. 9. 640224–640224. 18 indexed citations

12.

Wan, Zhuoya, Pearl Moharil, Yuzhe Liu, et al.. (2021). Polymeric Micelles in Cancer Immunotherapy. Molecules. 26(5). 1220–1220. 32 indexed citations

13.

Chen, Lujun, Runzi Sun, Dachuan Zhang, et al.. (2020). Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy. Cancer Immunology Research. 8(11). 1381–1392. 41 indexed citations

14.

Wan, Zhuoya, Runzi Sun, Pearl Moharil, et al.. (2020). Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. Journal of Leukocyte Biology. 109(2). 425–436. 18 indexed citations

15.

Yang, Min, Wenwen Du, Shaoxian Wu, et al.. (2020). Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment. OncoImmunology. 9(1). 1708064–1708064. 37 indexed citations

16.

Gao, Li, Bin Li, Jingyuan Wang, et al.. (2020). Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis. Hepatology Communications. 4(11). 1664–1679. 8 indexed citations

17.

Hu, Wenwei, Runzi Sun, Lujun Chen, Xiao Zheng, & Jingting Jiang. (2019). Prognostic significance of resident CD103+CD8+T cells in human colorectal cancer tissues. Acta Histochemica. 121(5). 657–663. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact